The present study demonstrates that the expression of c-Jun and c-Fos are elevated in gingival fibroblast cells treated with angiotensin Ⅱ and cyclosporine.The healthy human gingival tissues were collected and gingiv...The present study demonstrates that the expression of c-Jun and c-Fos are elevated in gingival fibroblast cells treated with angiotensin Ⅱ and cyclosporine.The healthy human gingival tissues were collected and gingival fibroblasts were isolated and cultured.We used RT-PCR and Western blot analysis to identify the expression of c-Jun and c-Fos in cyclosporine and angiotensin II treated human gingival fibroblast cells.We found that angiotensin Ⅱ in combination with cyclosporine induces c-Jun and c-Fos expressions significantly;however,the angiotensin Ⅱ antagonist losartan inhibits the expression of c-Jun and c-Fos(p<0.01).The data suggest that angiotensin Ⅱ in combination with cyclosporine modulates the expression of c-Jun and c-Fos in human gingival fibroblast cells.展开更多
Background: This Study Evaluate two state of Art techniques, Rapid Arc and large-field sliding window IMRT in terms of dosimetric end points and delivery time for head and neck cancer. Materials and Methods: 22 patien...Background: This Study Evaluate two state of Art techniques, Rapid Arc and large-field sliding window IMRT in terms of dosimetric end points and delivery time for head and neck cancer. Materials and Methods: 22 patients with head and neck cancer were selected for a planning comparative study. All patients went to CT-simulation in supine position. PTVs were delineated for two dose level of prescription 70 Gy to the boost-PTV70Gy and 54 Gy to the elective-PTV54Gy in 35 equal fraction/day. Simultaneous Integrated Boost (SIB) technique plan was generated for all patients and optimized with both techniques, Rapid Arc and IMRT with similar planning objectives. Dose of all plans of both techniques were calculated for 6MV photon using AAA implemented in Eclipse treatment planning system (10.0.39) with calculating grid size of 2.5 mm. Results: Comparison of Rapid Arc and IMRT plans in every patient showed significantly higher conformity index (CI95%) (p = 0.021) and sparing of the all OARs with Rapid Arc. The average homogeneity Index (HI95%) of lower prescribed dose target PTV54Gy which is in proximity to Higher dose prescribed target PTV70Gy was improved significantly with rapid Arc (p = 0.0001). D1% of spinal cord dose reduced significantly (p = 0.047) with Rapid Arc and the average mean dose of both left-parotid (21.26 ± 8.5 Gy), right-parotid (22.37 ± 7.44 Gy) were received lesser than with IMRT (22.78 ± 11.2 Gy and 24.1 ± 7.96 Gy) respectively. A significantly less monitor unit (MU) was required to deliver the plan (p < 0.00001) with significantly lesser treatment time (p < 0.00001). Conclusion: Rapid Arc technique was superior to IMRT in sparing the OARs without compromising target coverage and delivered the plan with lesser monitor unit and treatment time.展开更多
文摘The present study demonstrates that the expression of c-Jun and c-Fos are elevated in gingival fibroblast cells treated with angiotensin Ⅱ and cyclosporine.The healthy human gingival tissues were collected and gingival fibroblasts were isolated and cultured.We used RT-PCR and Western blot analysis to identify the expression of c-Jun and c-Fos in cyclosporine and angiotensin II treated human gingival fibroblast cells.We found that angiotensin Ⅱ in combination with cyclosporine induces c-Jun and c-Fos expressions significantly;however,the angiotensin Ⅱ antagonist losartan inhibits the expression of c-Jun and c-Fos(p<0.01).The data suggest that angiotensin Ⅱ in combination with cyclosporine modulates the expression of c-Jun and c-Fos in human gingival fibroblast cells.
文摘Background: This Study Evaluate two state of Art techniques, Rapid Arc and large-field sliding window IMRT in terms of dosimetric end points and delivery time for head and neck cancer. Materials and Methods: 22 patients with head and neck cancer were selected for a planning comparative study. All patients went to CT-simulation in supine position. PTVs were delineated for two dose level of prescription 70 Gy to the boost-PTV70Gy and 54 Gy to the elective-PTV54Gy in 35 equal fraction/day. Simultaneous Integrated Boost (SIB) technique plan was generated for all patients and optimized with both techniques, Rapid Arc and IMRT with similar planning objectives. Dose of all plans of both techniques were calculated for 6MV photon using AAA implemented in Eclipse treatment planning system (10.0.39) with calculating grid size of 2.5 mm. Results: Comparison of Rapid Arc and IMRT plans in every patient showed significantly higher conformity index (CI95%) (p = 0.021) and sparing of the all OARs with Rapid Arc. The average homogeneity Index (HI95%) of lower prescribed dose target PTV54Gy which is in proximity to Higher dose prescribed target PTV70Gy was improved significantly with rapid Arc (p = 0.0001). D1% of spinal cord dose reduced significantly (p = 0.047) with Rapid Arc and the average mean dose of both left-parotid (21.26 ± 8.5 Gy), right-parotid (22.37 ± 7.44 Gy) were received lesser than with IMRT (22.78 ± 11.2 Gy and 24.1 ± 7.96 Gy) respectively. A significantly less monitor unit (MU) was required to deliver the plan (p < 0.00001) with significantly lesser treatment time (p < 0.00001). Conclusion: Rapid Arc technique was superior to IMRT in sparing the OARs without compromising target coverage and delivered the plan with lesser monitor unit and treatment time.
